Compare AURA & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | NRIM |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.6M | 523.9M |
| IPO Year | 2021 | 2002 |
| Metric | AURA | NRIM |
|---|---|---|
| Price | $6.30 | $23.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $16.60 | ★ $30.33 |
| AVG Volume (30 Days) | ★ 869.6K | 118.4K |
| Earning Date | 11-12-2026 | 10-15-2026 |
| Dividend Yield | N/A | ★ 2.81% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $255,581,000.00 |
| Revenue This Year | N/A | $1.17 |
| Revenue Next Year | N/A | $25.45 |
| P/E Ratio | ★ N/A | $18.73 |
| Revenue Growth | N/A | ★ 30.43 |
| 52 Week Low | $4.73 | $21.68 |
| 52 Week High | $9.54 | $30.82 |
| Indicator | AURA | NRIM |
|---|---|---|
| Relative Strength Index (RSI) | 45.48 | 42.80 |
| Support Level | $6.04 | $23.74 |
| Resistance Level | $7.18 | $25.39 |
| Average True Range (ATR) | 0.28 | 0.55 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 30.66 | 46.02 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.